Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas
Open Access
- 1 January 2006
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 19 (12), 1563-1569
- https://doi.org/10.1038/modpathol.3800683
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Deletion Mapping of Chromosome 17 in Benign and Malignant Adrenocortical Tumors Associated with the Arg337His Mutation of the p53 Tumor Suppressor ProteinJournal of Clinical Endocrinology & Metabolism, 2005
- Matrix Metalloproteinase/Tissue Inhibitors of Matrix Metalloproteinase Phenotype Identifies Poor Prognosis Colorectal CancersClinical Cancer Research, 2004
- Role of the Insulin-like Growth Factor System in Adrenocortical Growth Control and CarcinogenesisHormone and Metabolic Research, 2004
- Adrenal Cortical Neoplasms in the Pediatric PopulationThe American Journal of Surgical Pathology, 2003
- Weiss System RevisitedThe American Journal of Surgical Pathology, 2002
- Insulin-Like Growth Factor I-Triggered Cell Migration and Invasion Are Mediated by Matrix Metalloproteinase-91Endocrinology, 1999
- EXPRESSION OF METALLOPROTEINASE 2 AND 9 AND THEIR INHIBITORS IN RENAL CELL CARCINOMAJournal of Urology, 1998
- EXPRESSION OF MATRIX METALLOPROTEINASE-7 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 IN HUMAN PROSTATEJournal of Urology, 1998
- Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissueHuman Pathology, 1992
- Pathologic Features of Prognostic Significance in Adrenocortical CarcinomaThe American Journal of Surgical Pathology, 1989